Opioids Market Outlook: Size, Share, Trends, Growth Analysis, Competitive Landscape & Forecast, 2026-2033

The Opioids Market size was valued at US$ 28.18 Billion in 2025 and is projected to reach US$ 43.92 Billion by 2033, growing at a CAGR of 5.7% during 2026–2033, driven by increasing chronic pain prevalence, expanding cancer care requirements, advanced abuse-deterrent formulations, broader healthcare access, and opportunities in controlled-release therapeutics and digital pain-management integration.

Report Coverage

Drug Class: Short Acting, Long Acting
Route of Administration: Oral, Parenteral, Transdermal, Others
Application: Pain Relief, Cough Suppression, Others
Distribution Channels: Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies

US$ 28.18 Bn Market size in 2025

US$ 43.92 Bn Market Size by 2033

5.70% CAGR, 2026 - 2033

2026-2033 Forecast Period

Download Sample PDF Buy Now

Format PDF + Excel + PPT

No. of Pages: 350

Category Life Sciences

Report Code: BMIPUB00039103

Last Updated: 2026-09-15

Author

Krishna Sunthwal

Analyst Connect

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. Opioids Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. Opioids Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. Opioids Market Global Analysis

6.2 Opioids Market Revenue 2022-2033 (US$ Billion)

6.3 Opioids Market Forecast Analysis

7. Opioids Market Analysis – by Drug Class

7.1 Short Acting

7.1.1 Overview
7.1.2 Short Acting: Opioids Market – Revenue and Forecast, 2022-2033 (US$ Billion)

7.2 Long Acting

7.2.1 Overview
7.2.2 Long Acting: Opioids Market – Revenue and Forecast, 2022-2033 (US$ Billion)

8. Opioids Market Analysis – by Route of Administration

8.1 Oral

8.1.1 Overview
8.1.2 Oral: Opioids Market – Revenue and Forecast, 2022-2033 (US$ Billion)

8.2 Parenteral

8.2.1 Overview
8.2.2 Parenteral: Opioids Market – Revenue and Forecast, 2022-2033 (US$ Billion)

8.3 Transdermal

8.3.1 Overview
8.3.2 Transdermal: Opioids Market – Revenue and Forecast, 2022-2033 (US$ Billion)

8.4 Others

8.4.1 Overview
8.4.2 Others: Opioids Market – Revenue and Forecast, 2022-2033 (US$ Billion)

9. Opioids Market Analysis – by Application

9.1 Pain Relief

9.1.1 Overview
9.1.2 Pain Relief: Opioids Market – Revenue and Forecast, 2022-2033 (US$ Billion)

9.2 Cough Suppression

9.2.1 Overview
9.2.2 Cough Suppression: Opioids Market – Revenue and Forecast, 2022-2033 (US$ Billion)

9.3 Others

9.3.1 Overview
9.3.2 Others: Opioids Market – Revenue and Forecast, 2022-2033 (US$ Billion)

10. Opioids Market Analysis – by Distribution Channels

10.1 Hospital Pharmacies

10.1.1 Overview
10.1.2 Hospital Pharmacies: Opioids Market – Revenue and Forecast, 2022-2033 (US$ Billion)

10.2 Retail Pharmacies & Drug Stores

10.2.1 Overview
10.2.2 Retail Pharmacies & Drug Stores: Opioids Market – Revenue and Forecast, 2022-2033 (US$ Billion)

10.3 Online Pharmacies

10.3.1 Overview
10.3.2 Online Pharmacies: Opioids Market – Revenue and Forecast, 2022-2033 (US$ Billion)

11. Opioids Market – Geographic Analysis

11.1 Overview

11.2 North America

11.2.1 Opioids Market Breakdown, by Key Country, 2026 and 2033 (%)
11.2.1.1 Opioids Market – Revenue and Forecast Analysis – by Country
11.2.1.1 US: Opioids Market – Revenue and Forecast to 2033 (US$ Billion)

11.2.1.1.1 US: Opioids Market Breakdown, by Drug Class
11.2.1.1.2 US: Opioids Market Breakdown, by Route of Administration
11.2.1.1.3 US: Opioids Market Breakdown, by Application
11.2.1.1.4 US: Opioids Market Breakdown, by Distribution Channels

11.2.1.2 Canada: Opioids Market – Revenue and Forecast to 2033 (US$ Billion)

11.2.1.2.1 Canada: Opioids Market Breakdown, by Drug Class
11.2.1.2.2 Canada: Opioids Market Breakdown, by Route of Administration
11.2.1.2.3 Canada: Opioids Market Breakdown, by Application
11.2.1.2.4 Canada: Opioids Market Breakdown, by Distribution Channels

11.2.1.3 Mexico: Opioids Market – Revenue and Forecast to 2033 (US$ Billion)

11.2.1.3.1 Mexico: Opioids Market Breakdown, by Drug Class
11.2.1.3.2 Mexico: Opioids Market Breakdown, by Route of Administration
11.2.1.3.3 Mexico: Opioids Market Breakdown, by Application
11.2.1.3.4 Mexico: Opioids Market Breakdown, by Distribution Channels

11.3 Europe

11.3.1 Opioids Market Breakdown, by Key Country, 2026 and 2033 (%)
11.3.1.1 Opioids Market – Revenue and Forecast Analysis – by Country
11.3.1.1 Germany: Opioids Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.1.1 Germany: Opioids Market Breakdown, by Drug Class
11.3.1.1.2 Germany: Opioids Market Breakdown, by Route of Administration
11.3.1.1.3 Germany: Opioids Market Breakdown, by Application
11.3.1.1.4 Germany: Opioids Market Breakdown, by Distribution Channels

11.3.1.2 Italy: Opioids Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.2.1 Italy: Opioids Market Breakdown, by Drug Class
11.3.1.2.2 Italy: Opioids Market Breakdown, by Route of Administration
11.3.1.2.3 Italy: Opioids Market Breakdown, by Application
11.3.1.2.4 Italy: Opioids Market Breakdown, by Distribution Channels

11.3.1.3 France: Opioids Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.3.1 France: Opioids Market Breakdown, by Drug Class
11.3.1.3.2 France: Opioids Market Breakdown, by Route of Administration
11.3.1.3.3 France: Opioids Market Breakdown, by Application
11.3.1.3.4 France: Opioids Market Breakdown, by Distribution Channels

11.3.1.4 U.K.: Opioids Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.4.1 U.K.: Opioids Market Breakdown, by Drug Class
11.3.1.4.2 U.K.: Opioids Market Breakdown, by Route of Administration
11.3.1.4.3 U.K.: Opioids Market Breakdown, by Application
11.3.1.4.4 U.K.: Opioids Market Breakdown, by Distribution Channels

11.3.1.5 Spain: Opioids Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.5.1 Spain: Opioids Market Breakdown, by Drug Class
11.3.1.5.2 Spain: Opioids Market Breakdown, by Route of Administration
11.3.1.5.3 Spain: Opioids Market Breakdown, by Application
11.3.1.5.4 Spain: Opioids Market Breakdown, by Distribution Channels

11.3.1.6 Belgium: Opioids Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.6.1 Belgium: Opioids Market Breakdown, by Drug Class
11.3.1.6.2 Belgium: Opioids Market Breakdown, by Route of Administration
11.3.1.6.3 Belgium: Opioids Market Breakdown, by Application
11.3.1.6.4 Belgium: Opioids Market Breakdown, by Distribution Channels

11.3.1.7 Netherlands: Opioids Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.7.1 Netherlands: Opioids Market Breakdown, by Drug Class
11.3.1.7.2 Netherlands: Opioids Market Breakdown, by Route of Administration
11.3.1.7.3 Netherlands: Opioids Market Breakdown, by Application
11.3.1.7.4 Netherlands: Opioids Market Breakdown, by Distribution Channels

11.3.1.8 Luxembourg: Opioids Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.8.1 Luxembourg: Opioids Market Breakdown, by Drug Class
11.3.1.8.2 Luxembourg: Opioids Market Breakdown, by Route of Administration
11.3.1.8.3 Luxembourg: Opioids Market Breakdown, by Application
11.3.1.8.4 Luxembourg: Opioids Market Breakdown, by Distribution Channels

11.3.1.9 Norway: Opioids Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.9.1 Norway: Opioids Market Breakdown, by Drug Class
11.3.1.9.2 Norway: Opioids Market Breakdown, by Route of Administration
11.3.1.9.3 Norway: Opioids Market Breakdown, by Application
11.3.1.9.4 Norway: Opioids Market Breakdown, by Distribution Channels

11.3.1.10 Finland: Opioids Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.10.1 Finland: Opioids Market Breakdown, by Drug Class
11.3.1.10.2 Finland: Opioids Market Breakdown, by Route of Administration
11.3.1.10.3 Finland: Opioids Market Breakdown, by Application
11.3.1.10.4 Finland: Opioids Market Breakdown, by Distribution Channels

11.3.1.11 Denmark: Opioids Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.11.1 Denmark: Opioids Market Breakdown, by Drug Class
11.3.1.11.2 Denmark: Opioids Market Breakdown, by Route of Administration
11.3.1.11.3 Denmark: Opioids Market Breakdown, by Application
11.3.1.11.4 Denmark: Opioids Market Breakdown, by Distribution Channels

11.3.1.12 Sweden: Opioids Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.12.1 Sweden: Opioids Market Breakdown, by Drug Class
11.3.1.12.2 Sweden: Opioids Market Breakdown, by Route of Administration
11.3.1.12.3 Sweden: Opioids Market Breakdown, by Application
11.3.1.12.4 Sweden: Opioids Market Breakdown, by Distribution Channels

11.3.1.13 Switzerland: Opioids Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.13.1 Switzerland: Opioids Market Breakdown, by Drug Class
11.3.1.13.2 Switzerland: Opioids Market Breakdown, by Route of Administration
11.3.1.13.3 Switzerland: Opioids Market Breakdown, by Application
11.3.1.13.4 Switzerland: Opioids Market Breakdown, by Distribution Channels

11.3.1.14 Austria: Opioids Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.14.1 Austria: Opioids Market Breakdown, by Drug Class
11.3.1.14.2 Austria: Opioids Market Breakdown, by Route of Administration
11.3.1.14.3 Austria: Opioids Market Breakdown, by Application
11.3.1.14.4 Austria: Opioids Market Breakdown, by Distribution Channels

11.3.1.15 Greece: Opioids Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.15.1 Greece: Opioids Market Breakdown, by Drug Class
11.3.1.15.2 Greece: Opioids Market Breakdown, by Route of Administration
11.3.1.15.3 Greece: Opioids Market Breakdown, by Application
11.3.1.15.4 Greece: Opioids Market Breakdown, by Distribution Channels

11.3.1.16 Portugal: Opioids Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.16.1 Portugal: Opioids Market Breakdown, by Drug Class
11.3.1.16.2 Portugal: Opioids Market Breakdown, by Route of Administration
11.3.1.16.3 Portugal: Opioids Market Breakdown, by Application
11.3.1.16.4 Portugal: Opioids Market Breakdown, by Distribution Channels

11.3.1.17 Russia: Opioids Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.17.1 Russia: Opioids Market Breakdown, by Drug Class
11.3.1.17.2 Russia: Opioids Market Breakdown, by Route of Administration
11.3.1.17.3 Russia: Opioids Market Breakdown, by Application
11.3.1.17.4 Russia: Opioids Market Breakdown, by Distribution Channels

11.3.1.18 Poland: Opioids Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.18.1 Poland: Opioids Market Breakdown, by Drug Class
11.3.1.18.2 Poland: Opioids Market Breakdown, by Route of Administration
11.3.1.18.3 Poland: Opioids Market Breakdown, by Application
11.3.1.18.4 Poland: Opioids Market Breakdown, by Distribution Channels

11.3.1.19 Romania: Opioids Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.19.1 Romania: Opioids Market Breakdown, by Drug Class
11.3.1.19.2 Romania: Opioids Market Breakdown, by Route of Administration
11.3.1.19.3 Romania: Opioids Market Breakdown, by Application
11.3.1.19.4 Romania: Opioids Market Breakdown, by Distribution Channels

11.3.1.20 Czech Republic: Opioids Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.20.1 Czech Republic: Opioids Market Breakdown, by Drug Class
11.3.1.20.2 Czech Republic: Opioids Market Breakdown, by Route of Administration
11.3.1.20.3 Czech Republic: Opioids Market Breakdown, by Application
11.3.1.20.4 Czech Republic: Opioids Market Breakdown, by Distribution Channels

11.3.1.21 Ukraine: Opioids Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.21.1 Ukraine: Opioids Market Breakdown, by Drug Class
11.3.1.21.2 Ukraine: Opioids Market Breakdown, by Route of Administration
11.3.1.21.3 Ukraine: Opioids Market Breakdown, by Application
11.3.1.21.4 Ukraine: Opioids Market Breakdown, by Distribution Channels

11.3.1.22 Slovakia: Opioids Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.22.1 Slovakia: Opioids Market Breakdown, by Drug Class
11.3.1.22.2 Slovakia: Opioids Market Breakdown, by Route of Administration
11.3.1.22.3 Slovakia: Opioids Market Breakdown, by Application
11.3.1.22.4 Slovakia: Opioids Market Breakdown, by Distribution Channels

11.3.1.23 Bulgaria: Opioids Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.23.1 Bulgaria: Opioids Market Breakdown, by Drug Class
11.3.1.23.2 Bulgaria: Opioids Market Breakdown, by Route of Administration
11.3.1.23.3 Bulgaria: Opioids Market Breakdown, by Application
11.3.1.23.4 Bulgaria: Opioids Market Breakdown, by Distribution Channels

11.4 Asia-Pacific

11.4.1 Opioids Market Breakdown, by Key Country, 2026 and 2033 (%)
11.4.1.1 Opioids Market – Revenue and Forecast Analysis – by Country
11.4.1.1 China: Opioids Market – Revenue and Forecast to 2033 (US$ Billion)

11.4.1.1.1 China: Opioids Market Breakdown, by Drug Class
11.4.1.1.2 China: Opioids Market Breakdown, by Route of Administration
11.4.1.1.3 China: Opioids Market Breakdown, by Application
11.4.1.1.4 China: Opioids Market Breakdown, by Distribution Channels

11.4.1.2 Japan: Opioids Market – Revenue and Forecast to 2033 (US$ Billion)

11.4.1.2.1 Japan: Opioids Market Breakdown, by Drug Class
11.4.1.2.2 Japan: Opioids Market Breakdown, by Route of Administration
11.4.1.2.3 Japan: Opioids Market Breakdown, by Application
11.4.1.2.4 Japan: Opioids Market Breakdown, by Distribution Channels

11.4.1.3 South Korea: Opioids Market – Revenue and Forecast to 2033 (US$ Billion)

11.4.1.3.1 South Korea: Opioids Market Breakdown, by Drug Class
11.4.1.3.2 South Korea: Opioids Market Breakdown, by Route of Administration
11.4.1.3.3 South Korea: Opioids Market Breakdown, by Application
11.4.1.3.4 South Korea: Opioids Market Breakdown, by Distribution Channels

11.4.1.4 India: Opioids Market – Revenue and Forecast to 2033 (US$ Billion)

11.4.1.4.1 India: Opioids Market Breakdown, by Drug Class
11.4.1.4.2 India: Opioids Market Breakdown, by Route of Administration
11.4.1.4.3 India: Opioids Market Breakdown, by Application
11.4.1.4.4 India: Opioids Market Breakdown, by Distribution Channels

11.4.1.5 Australia: Opioids Market – Revenue and Forecast to 2033 (US$ Billion)

11.4.1.5.1 Australia: Opioids Market Breakdown, by Drug Class
11.4.1.5.2 Australia: Opioids Market Breakdown, by Route of Administration
11.4.1.5.3 Australia: Opioids Market Breakdown, by Application
11.4.1.5.4 Australia: Opioids Market Breakdown, by Distribution Channels

11.4.1.6 New Zealand: Opioids Market – Revenue and Forecast to 2033 (US$ Billion)

11.4.1.6.1 New Zealand: Opioids Market Breakdown, by Drug Class
11.4.1.6.2 New Zealand: Opioids Market Breakdown, by Route of Administration
11.4.1.6.3 New Zealand: Opioids Market Breakdown, by Application
11.4.1.6.4 New Zealand: Opioids Market Breakdown, by Distribution Channels

11.4.1.7 Indonesia: Opioids Market – Revenue and Forecast to 2033 (US$ Billion)

11.4.1.7.1 Indonesia: Opioids Market Breakdown, by Drug Class
11.4.1.7.2 Indonesia: Opioids Market Breakdown, by Route of Administration
11.4.1.7.3 Indonesia: Opioids Market Breakdown, by Application
11.4.1.7.4 Indonesia: Opioids Market Breakdown, by Distribution Channels

11.4.1.8 Malaysia: Opioids Market – Revenue and Forecast to 2033 (US$ Billion)

11.4.1.8.1 Malaysia: Opioids Market Breakdown, by Drug Class
11.4.1.8.2 Malaysia: Opioids Market Breakdown, by Route of Administration
11.4.1.8.3 Malaysia: Opioids Market Breakdown, by Application
11.4.1.8.4 Malaysia: Opioids Market Breakdown, by Distribution Channels

11.4.1.9 Philippines: Opioids Market – Revenue and Forecast to 2033 (US$ Billion)

11.4.1.9.1 Philippines: Opioids Market Breakdown, by Drug Class
11.4.1.9.2 Philippines: Opioids Market Breakdown, by Route of Administration
11.4.1.9.3 Philippines: Opioids Market Breakdown, by Application
11.4.1.9.4 Philippines: Opioids Market Breakdown, by Distribution Channels

11.4.1.10 Singapore: Opioids Market – Revenue and Forecast to 2033 (US$ Billion)

11.4.1.10.1 Singapore: Opioids Market Breakdown, by Drug Class
11.4.1.10.2 Singapore: Opioids Market Breakdown, by Route of Administration
11.4.1.10.3 Singapore: Opioids Market Breakdown, by Application
11.4.1.10.4 Singapore: Opioids Market Breakdown, by Distribution Channels

11.4.1.11 Thailand: Opioids Market – Revenue and Forecast to 2033 (US$ Billion)

11.4.1.11.1 Thailand: Opioids Market Breakdown, by Drug Class
11.4.1.11.2 Thailand: Opioids Market Breakdown, by Route of Administration
11.4.1.11.3 Thailand: Opioids Market Breakdown, by Application
11.4.1.11.4 Thailand: Opioids Market Breakdown, by Distribution Channels

11.4.1.12 Vietnam: Opioids Market – Revenue and Forecast to 2033 (US$ Billion)

11.4.1.12.1 Vietnam: Opioids Market Breakdown, by Drug Class
11.4.1.12.2 Vietnam: Opioids Market Breakdown, by Route of Administration
11.4.1.12.3 Vietnam: Opioids Market Breakdown, by Application
11.4.1.12.4 Vietnam: Opioids Market Breakdown, by Distribution Channels

11.4.1.13 Taiwan: Opioids Market – Revenue and Forecast to 2033 (US$ Billion)

11.4.1.13.1 Taiwan: Opioids Market Breakdown, by Drug Class
11.4.1.13.2 Taiwan: Opioids Market Breakdown, by Route of Administration
11.4.1.13.3 Taiwan: Opioids Market Breakdown, by Application
11.4.1.13.4 Taiwan: Opioids Market Breakdown, by Distribution Channels

11.4.1.14 Bangladesh: Opioids Market – Revenue and Forecast to 2033 (US$ Billion)

11.4.1.14.1 Bangladesh: Opioids Market Breakdown, by Drug Class
11.4.1.14.2 Bangladesh: Opioids Market Breakdown, by Route of Administration
11.4.1.14.3 Bangladesh: Opioids Market Breakdown, by Application
11.4.1.14.4 Bangladesh: Opioids Market Breakdown, by Distribution Channels

11.5 South and Central America

11.5.1 Opioids Market Breakdown, by Key Country, 2026 and 2033 (%)
11.5.1.1 Opioids Market – Revenue and Forecast Analysis – by Country
11.5.1.1 Brazil: Opioids Market – Revenue and Forecast to 2033 (US$ Billion)

11.5.1.1.1 Brazil: Opioids Market Breakdown, by Drug Class
11.5.1.1.2 Brazil: Opioids Market Breakdown, by Route of Administration
11.5.1.1.3 Brazil: Opioids Market Breakdown, by Application
11.5.1.1.4 Brazil: Opioids Market Breakdown, by Distribution Channels

11.5.1.2 Argentina: Opioids Market – Revenue and Forecast to 2033 (US$ Billion)

11.5.1.2.1 Argentina: Opioids Market Breakdown, by Drug Class
11.5.1.2.2 Argentina: Opioids Market Breakdown, by Route of Administration
11.5.1.2.3 Argentina: Opioids Market Breakdown, by Application
11.5.1.2.4 Argentina: Opioids Market Breakdown, by Distribution Channels

11.5.1.3 Chile: Opioids Market – Revenue and Forecast to 2033 (US$ Billion)

11.5.1.3.1 Chile: Opioids Market Breakdown, by Drug Class
11.5.1.3.2 Chile: Opioids Market Breakdown, by Route of Administration
11.5.1.3.3 Chile: Opioids Market Breakdown, by Application
11.5.1.3.4 Chile: Opioids Market Breakdown, by Distribution Channels

11.5.1.4 Colombia: Opioids Market – Revenue and Forecast to 2033 (US$ Billion)

11.5.1.4.1 Colombia: Opioids Market Breakdown, by Drug Class
11.5.1.4.2 Colombia: Opioids Market Breakdown, by Route of Administration
11.5.1.4.3 Colombia: Opioids Market Breakdown, by Application
11.5.1.4.4 Colombia: Opioids Market Breakdown, by Distribution Channels

11.5.1.5 Peru: Opioids Market – Revenue and Forecast to 2033 (US$ Billion)

11.5.1.5.1 Peru: Opioids Market Breakdown, by Drug Class
11.5.1.5.2 Peru: Opioids Market Breakdown, by Route of Administration
11.5.1.5.3 Peru: Opioids Market Breakdown, by Application
11.5.1.5.4 Peru: Opioids Market Breakdown, by Distribution Channels

11.6 Middle East and Africa

11.6.1 Opioids Market Breakdown, by Key Country, 2026 and 2033 (%)
11.6.1.1 Opioids Market – Revenue and Forecast Analysis – by Country
11.6.1.1 Saudi Arabia: Opioids Market – Revenue and Forecast to 2033 (US$ Billion)

11.6.1.1.1 Saudi Arabia: Opioids Market Breakdown, by Drug Class
11.6.1.1.2 Saudi Arabia: Opioids Market Breakdown, by Route of Administration
11.6.1.1.3 Saudi Arabia: Opioids Market Breakdown, by Application
11.6.1.1.4 Saudi Arabia: Opioids Market Breakdown, by Distribution Channels

11.6.1.2 United Arab Emirates: Opioids Market – Revenue and Forecast to 2033 (US$ Billion)

11.6.1.2.1 United Arab Emirates: Opioids Market Breakdown, by Drug Class
11.6.1.2.2 United Arab Emirates: Opioids Market Breakdown, by Route of Administration
11.6.1.2.3 United Arab Emirates: Opioids Market Breakdown, by Application
11.6.1.2.4 United Arab Emirates: Opioids Market Breakdown, by Distribution Channels

11.6.1.3 Kuwait: Opioids Market – Revenue and Forecast to 2033 (US$ Billion)

11.6.1.3.1 Kuwait: Opioids Market Breakdown, by Drug Class
11.6.1.3.2 Kuwait: Opioids Market Breakdown, by Route of Administration
11.6.1.3.3 Kuwait: Opioids Market Breakdown, by Application
11.6.1.3.4 Kuwait: Opioids Market Breakdown, by Distribution Channels

11.6.1.4 Bahrain: Opioids Market – Revenue and Forecast to 2033 (US$ Billion)

11.6.1.4.1 Bahrain: Opioids Market Breakdown, by Drug Class
11.6.1.4.2 Bahrain: Opioids Market Breakdown, by Route of Administration
11.6.1.4.3 Bahrain: Opioids Market Breakdown, by Application
11.6.1.4.4 Bahrain: Opioids Market Breakdown, by Distribution Channels

11.6.1.5 Qatar: Opioids Market – Revenue and Forecast to 2033 (US$ Billion)

11.6.1.5.1 Qatar: Opioids Market Breakdown, by Drug Class
11.6.1.5.2 Qatar: Opioids Market Breakdown, by Route of Administration
11.6.1.5.3 Qatar: Opioids Market Breakdown, by Application
11.6.1.5.4 Qatar: Opioids Market Breakdown, by Distribution Channels

11.6.1.6 Oman: Opioids Market – Revenue and Forecast to 2033 (US$ Billion)

11.6.1.6.1 Oman: Opioids Market Breakdown, by Drug Class
11.6.1.6.2 Oman: Opioids Market Breakdown, by Route of Administration
11.6.1.6.3 Oman: Opioids Market Breakdown, by Application
11.6.1.6.4 Oman: Opioids Market Breakdown, by Distribution Channels

11.6.1.7 Turkiye: Opioids Market – Revenue and Forecast to 2033 (US$ Billion)

11.6.1.7.1 Turkiye: Opioids Market Breakdown, by Drug Class
11.6.1.7.2 Turkiye: Opioids Market Breakdown, by Route of Administration
11.6.1.7.3 Turkiye: Opioids Market Breakdown, by Application
11.6.1.7.4 Turkiye: Opioids Market Breakdown, by Distribution Channels

11.6.1.8 South Africa: Opioids Market – Revenue and Forecast to 2033 (US$ Billion)

11.6.1.8.1 South Africa: Opioids Market Breakdown, by Drug Class
11.6.1.8.2 South Africa: Opioids Market Breakdown, by Route of Administration
11.6.1.8.3 South Africa: Opioids Market Breakdown, by Application
11.6.1.8.4 South Africa: Opioids Market Breakdown, by Distribution Channels

11.6.1.9 Egypt: Opioids Market – Revenue and Forecast to 2033 (US$ Billion)

11.6.1.9.1 Egypt: Opioids Market Breakdown, by Drug Class
11.6.1.9.2 Egypt: Opioids Market Breakdown, by Route of Administration
11.6.1.9.3 Egypt: Opioids Market Breakdown, by Application
11.6.1.9.4 Egypt: Opioids Market Breakdown, by Distribution Channels

11.6.1.10 Nigeria: Opioids Market – Revenue and Forecast to 2033 (US$ Billion)

11.6.1.10.1 Nigeria: Opioids Market Breakdown, by Drug Class
11.6.1.10.2 Nigeria: Opioids Market Breakdown, by Route of Administration
11.6.1.10.3 Nigeria: Opioids Market Breakdown, by Application
11.6.1.10.4 Nigeria: Opioids Market Breakdown, by Distribution Channels

11.6.1.11 Algeria: Opioids Market – Revenue and Forecast to 2033 (US$ Billion)

11.6.1.11.1 Algeria: Opioids Market Breakdown, by Drug Class
11.6.1.11.2 Algeria: Opioids Market Breakdown, by Route of Administration
11.6.1.11.3 Algeria: Opioids Market Breakdown, by Application
11.6.1.11.4 Algeria: Opioids Market Breakdown, by Distribution Channels

12. Competitive Landscape

12.1 Heat Map Analysis

12.2 Company Positioning and Concentration

13. Industry Landscape

13.1 Overview

13.2 Market Initiative

13.3 Partnerships and Collaborations

13.4 Other Developments

14. Company Profiles

14.1 Pfizer Inc.

14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments

14.2 Viatris Inc.

14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments

14.3 Hikma Pharmaceuticals PLC

14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments

14.4 Teva Pharmaceutical Industries Ltd.

14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments

14.5 Endo International plc

14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments

14.6 Mallinckrodt plc

14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments

14.7 Purdue Pharma L.P.

14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments

14.8 Sun Pharmaceutical Industries Limited

14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments

14.9 Amneal Pharmaceuticals, Inc.

14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments

14.10 Indivior PLC

14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments

15. Appendix

15.1 About Business Market Insights

15.2 List of Abbreviations

Access the Full Opioids Market Report

Get segment-level forecasts, regional estimates, competitive benchmarking, company profiles and downloadable Excel datasets.

Download Sample Request Customization